orphan drugs

Drug development and working with specialised Rare Disease networks

https://pharmaphorum.com/r-d/drug-development-working-specialised-rare-disease-networks/

The power of R&D collaborations to improve outcomes in rare diseases

https://pharmaphorum.com/webinars/pharma-research-outcomes-rare-diseases/

How does HTA for orphan drugs differ across Europe?

https://pharmaphorum.com/views-analysis-market-access/how-does-hta-for-orphan-drugs-differ-across-europe/

The biggest challenges facing rare disease pharma – and how the industry can tackle them

https://pharmaphorum.com/r-d/views-analysis-r-d/biggest-challenges-rare-disease/

Exclusive Bionical EMAS speaker interview released for Orphan Drugs & Rare Diseases

https://pharmaphorum.com/partner-content/exclusive-bionical-emas-speaker-interview-released-for-orphan-drugs-rare-diseases/

Who will be the biggest pharma players in orphan drugs?

https://pharmaphorum.com/views-analysis-sales-marketing/who-will-be-the-biggest-pharma-players-in-orphan-drugs/

Mike Page, Alexion Pharmaceuticals invite to SMi’s Orphan Drugs & Rare Diseases

https://pharmaphorum.com/partner-content/mike-page-alexion-pharmaceuticals-invite-to-smis-orphan-drugs-rare-diseases/

Alexion Pharmaceuticals & Minoryx Therapeutics to Present at SMi’s Orphan Drugs Event

https://pharmaphorum.com/partner-content/alexion-pharmaceuticals-minoryx-therapeutics-to-present-at-smis-orphan-drugs-event/

Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019

https://pharmaphorum.com/partner-content/invitation-to-smis-orphan-drugs-rare-diseases-conference-2019/

1 2 3 4

Close in 10 seconds

Pharmaphorum.com

Search